Static Chart Legend Biotech Corporation

Equities

Real-time Estimate Cboe BZX Other stock markets 02:49:11 2024-06-06 pm EDT			5-day change	1st Jan Change
46.27 ^USD	+6.03%		+5.77%	-23.83%

Jun. 03	Legend Biotech Says Phase 2 Trial of Carvykti to Treat Multiple Myeloma Showed 'Deep, Durable' Responses	MT
Jun. 03	Legend Biotech Corporation Shares Data on the Earlier Use to Date of CARVYKTI in the Treatment of Multiple Myeloma and Important Subgroup Analyses At ASCO and EHA	CI

Duration

Period